Literature DB >> 26408158

Distribution of the Endocannabinoid System in the Central Nervous System.

Sherry Shu-Jung Hu1, Ken Mackie2,3.   

Abstract

The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), the enzymes that synthesize and degrade endocannabinoids, and the receptors that transduce the effects of endocannabinoids. Much of what we know about the function of endocannabinoids comes from studies that combine localization of endocannabinoid system components with physiological or behavioral approaches. This review will focus on the localization of the best-known components of the endocannabinoid system for which the strongest anatomical evidence exists.

Entities:  

Keywords:  CB1 cannabinoid receptor; Immunocytochemistry; In situ hybridization

Mesh:

Substances:

Year:  2015        PMID: 26408158     DOI: 10.1007/978-3-319-20825-1_3

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  40 in total

1.  Mechanism for differential recruitment of orbitostriatal transmission during actions and outcomes following chronic alcohol exposure.

Authors:  Rafael Renteria; Christian Cazares; Emily T Baltz; Drew C Schreiner; Ege A Yalcinbas; Thomas Steinkellner; Thomas S Hnasko; Christina M Gremel
Journal:  Elife       Date:  2021-03-17       Impact factor: 8.140

2.  Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.

Authors:  Giorgia Galiazzo; Fiorella Giancola; Agnese Stanzani; Federico Fracassi; Chiara Bernardini; Monica Forni; Marco Pietra; Roberto Chiocchetti
Journal:  Histochem Cell Biol       Date:  2018-06-07       Impact factor: 4.304

Review 3.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

4.  Natural Cannabinoids as Templates for Sleep Disturbances Treatments.

Authors:  Eric Murillo-Rodríguez; Sérgio Machado; Claudio Imperatori; Tetsuya Yamamoto; Henning Budde
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

Authors:  Gaurav Bedse; Mathew N Hill; Sachin Patel
Journal:  Biol Psychiatry       Date:  2020-03-17       Impact factor: 13.382

Review 6.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

7.  Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.

Authors:  Akshayan Vimalanathan; Darryl C Gidyk; Mustansir Diwan; Flavia V Gouveia; Nir Lipsman; Peter Giacobbe; José N Nobrega; Clement Hamani
Journal:  Neuropharmacology       Date:  2020-01-13       Impact factor: 5.250

8.  Cannabinoid CB2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells.

Authors:  M Galán-Ganga; R Del Río; N Jiménez-Moreno; M Díaz-Guerra; I Lastres-Becker
Journal:  Cell Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.046

Review 9.  Brain activity of anandamide: a rewarding bliss?

Authors:  Maria Scherma; Paolo Masia; Valentina Satta; Walter Fratta; Paola Fadda; Gianluigi Tanda
Journal:  Acta Pharmacol Sin       Date:  2018-07-26       Impact factor: 6.150

Review 10.  Cannabinoids and the expanded endocannabinoid system in neurological disorders.

Authors:  Luigia Cristino; Tiziana Bisogno; Vincenzo Di Marzo
Journal:  Nat Rev Neurol       Date:  2019-12-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.